首页 > 最新文献

Virginia medical quarterly : VMQ最新文献

英文 中文
The problem of antibiotic resistance. 抗生素耐药性的问题。
Pub Date : 1997-01-01
J O Hendley
{"title":"The problem of antibiotic resistance.","authors":"J O Hendley","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 2","pages":"96-8"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20050719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Virginia Health Care Foundation. Meeting the challenge. 弗吉尼亚卫生保健基金会。迎接挑战。
Pub Date : 1997-01-01
L B Middleditch
{"title":"The Virginia Health Care Foundation. Meeting the challenge.","authors":"L B Middleditch","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 3","pages":"166"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20171389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deferred demise. 递延的灭亡。
Pub Date : 1997-01-01
J L McClenahan
{"title":"Deferred demise.","authors":"J L McClenahan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 4","pages":"228-9"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20270806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urokinase thrombolysis as initial therapy for acute and non-acute ischemic extremities. 尿激酶溶栓作为急性和非急性缺血性肢体的初始治疗。
Pub Date : 1997-01-01
D Byrne, W D Byrne, P D Kiernan, W Harshaw, J Bryne, T Fulcher, L Stanton, S Goodman, M Karnaze

Limb ischemia, both acute and chronic, presents a risk to life and limb with mortality rates from 3% to 37% and amputation rates of the same range. Our experience with urokinase thrombolysis as the initial therapy for acute and non-acute ischemic extremities over 57 consecutive cases of native arterial occlusion by either thrombus or embolus has resulted in no mortality and only 3.5% requiring amputation (2 of 57). In 74% of cases initial thrombolytic therapy was followed by either balloon angioplasty (35 patients) or surgery (7 patients) to relieve the underlying cause of obstruction (i.e., stenosis, occlusion or aneurysm). Thrombolysis alone was sufficient and effective treatment in the remaining 26% (15 patients).

急性和慢性肢体缺血对生命和肢体构成威胁,死亡率为3%至37%,截肢率也在同一范围内。根据我们的经验,尿激酶溶栓作为急性和非急性缺血性肢体的初始治疗,连续治疗了57例由血栓或栓子引起的原生动脉闭塞,没有导致死亡,只有3.5%的患者需要截肢(57例中的2例)。在74%的病例中,最初的溶栓治疗之后,要么是球囊血管成形术(35例),要么是手术(7例),以缓解梗阻的根本原因(即狭窄、闭塞或动脉瘤)。在其余的26%(15例)患者中,单独溶栓是充分有效的治疗方法。
{"title":"Urokinase thrombolysis as initial therapy for acute and non-acute ischemic extremities.","authors":"D Byrne,&nbsp;W D Byrne,&nbsp;P D Kiernan,&nbsp;W Harshaw,&nbsp;J Bryne,&nbsp;T Fulcher,&nbsp;L Stanton,&nbsp;S Goodman,&nbsp;M Karnaze","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Limb ischemia, both acute and chronic, presents a risk to life and limb with mortality rates from 3% to 37% and amputation rates of the same range. Our experience with urokinase thrombolysis as the initial therapy for acute and non-acute ischemic extremities over 57 consecutive cases of native arterial occlusion by either thrombus or embolus has resulted in no mortality and only 3.5% requiring amputation (2 of 57). In 74% of cases initial thrombolytic therapy was followed by either balloon angioplasty (35 patients) or surgery (7 patients) to relieve the underlying cause of obstruction (i.e., stenosis, occlusion or aneurysm). Thrombolysis alone was sufficient and effective treatment in the remaining 26% (15 patients).</p>","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 1","pages":"41-4"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19971071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophagitis associated with alendronate sodium. 阿仑膦酸钠引起的食管炎。
Pub Date : 1997-01-01
E Pizzani, G Valenzuela
{"title":"Esophagitis associated with alendronate sodium.","authors":"E Pizzani,&nbsp;G Valenzuela","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 3","pages":"181-2"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20171393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The health care provider's duty to report child abuse in Virginia. 在弗吉尼亚州,医疗服务提供者报告虐待儿童的责任。
Pub Date : 1997-01-01
J C Fuhr
{"title":"The health care provider's duty to report child abuse in Virginia.","authors":"J C Fuhr","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 2","pages":"78-80"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20050717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical device reporting regulations. 医疗器械报告条例。
Pub Date : 1997-01-01
P G Gill
{"title":"Medical device reporting regulations.","authors":"P G Gill","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 1","pages":"8-12"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19971069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community partnerships work. 社区伙伴关系起作用。
Pub Date : 1997-01-01
S T Selden, N M Welch

This adult care program epitomizes the values most recently espoused in debates on health care reform. Public/private partnerships are strengthened by emphasizing unique contributions of all resources of health care: private physicians, private pharmacists, local government, local health departments, community hospitals, business leaders, volunteer free clinics and a private medical school. The success of this program is also contingent on a high degree of patient responsibility. Patients must demonstrate a willingness to share in their care through improved capabilities of self-management. They must share in the cost of their medications, and if there is a propensity to abuse the services (unnecessary ER usage, doctor hopping), they run the risk of termination of services. Expectations are high and patients are being taught how to meet them. The next step is an intensive evaluation of outcome measures. It is felt that this evaluation must extend over a minimum of 5 years in order to be valid and demonstrate trends. We are currently pursuing funding for such an evaluation.

这个成人护理计划集中体现了最近在医疗改革辩论中所支持的价值观。通过强调所有保健资源的独特贡献,加强了公共/私营伙伴关系:私人医生、私人药剂师、地方政府、地方卫生部门、社区医院、商业领袖、志愿免费诊所和私立医学院。这个项目的成功也取决于病人的高度责任感。患者必须表现出愿意通过提高自我管理能力来分享他们的护理。他们必须分担他们的药物费用,如果有滥用服务的倾向(不必要的急诊室使用,医生跳),他们冒着终止服务的风险。人们对病人的期望很高,他们被教导如何满足这些期望。下一步是对结果措施进行深入评估。人们认为,这项评价必须至少延长5年,才能有效并显示出趋势。我们目前正在为这样的评估寻求资金。
{"title":"Community partnerships work.","authors":"S T Selden,&nbsp;N M Welch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This adult care program epitomizes the values most recently espoused in debates on health care reform. Public/private partnerships are strengthened by emphasizing unique contributions of all resources of health care: private physicians, private pharmacists, local government, local health departments, community hospitals, business leaders, volunteer free clinics and a private medical school. The success of this program is also contingent on a high degree of patient responsibility. Patients must demonstrate a willingness to share in their care through improved capabilities of self-management. They must share in the cost of their medications, and if there is a propensity to abuse the services (unnecessary ER usage, doctor hopping), they run the risk of termination of services. Expectations are high and patients are being taught how to meet them. The next step is an intensive evaluation of outcome measures. It is felt that this evaluation must extend over a minimum of 5 years in order to be valid and demonstrate trends. We are currently pursuing funding for such an evaluation.</p>","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 3","pages":"147-8"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20171384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving access to health care for all Virginians. Trigon Blue Cross Blue Shield. 改善所有弗吉尼亚人获得医疗保健的机会。三角蓝十字蓝盾。
Pub Date : 1997-01-01
R Grinnan
{"title":"Improving access to health care for all Virginians. Trigon Blue Cross Blue Shield.","authors":"R Grinnan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 3","pages":"160-1"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20171387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two chairs and beyond: protecting our patients and our medical profession. 两张椅子或更多:保护我们的病人和我们的医疗职业。
Pub Date : 1997-01-01
P Wootton
{"title":"Two chairs and beyond: protecting our patients and our medical profession.","authors":"P Wootton","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":77458,"journal":{"name":"Virginia medical quarterly : VMQ","volume":"124 3","pages":"170-3"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20171391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Virginia medical quarterly : VMQ
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1